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Abstract 27 
The human body is colonized by an enormous population of bacteria (microbiota) that outnumbers 28 
the human somatic and germ cells and provides the host with additional coding capacity and 29 
metabolic activities. Among the human gut microbiota are health-promoting indigenous species, 30 
also referred to as probiotic bacteria, which are commonly consumed as live dietary supplements. 31 
Although there is a growing list of health benefits provided by the consumption of probiotics, their 32 
precise mechanisms of action remain largely unknown. Recent genomics based studies 33 
(probiogenomics) are starting to provide insights into the ways probiotic bacteria sense and adapt to 34 
the gastrointestinal tract environment.  In this review, we will discuss the application of 35 
probiogenomics in the elucidation of the molecular basis of probiosis using the well recognized 36 
model probiotic bacteria Bifidobacterium and Lactobacillus as examples. 37 
 3
 38 
The availability of the sequence of the human genome has paved the way for a better understanding 39 
of the genetic basis for many aspects of human health and disease. However, fully understanding 40 
the human genotype, and its relationship with health and disease susceptibility, requires better 41 
information explaining how environmental and developmental factors interact with the genome to 42 
influence health status. Human beings are colonized by, or transiently harbour, a wide, complex and 43 
dynamic collection of bacteria that outnumber the human somatic and germ cells, and that 44 
collectively represent significantly more genetic variety than the genome of their host1. However, at 45 
the present time, the components of the human microbiota remain poorly identified and 46 
characterized. Recent culture-independent studies of the microbiota of the human gastrointestinal 47 
tract (GIT) have identified more than 1000 phylotypes, representing over 7000 strains and 48 
belonging to eight major phyla1-4 (see also5 for an overview).  49 
It has been suggested that the composition of the gut microbiota is the result of selective 50 
pressure imposed by the host, and further modulated by competition between constituent bacterial 51 
members6. The interactions between various bacteria and the human host can be categorized as a 52 
continuum ranging from symbiosis to commensalism and through to pathogenesis, where the two 53 
former relationships can be grouped as mutualism (Fig. 1). In the human gut environment, the 54 
adaptive co-evolution of humans and bacteria may lead to the development of commensal 55 
relationships, where neither partner is disadvantaged, or symbiotic relationships where unique 56 
metabolic activities or other benefits are provided. The intestinal microbiota contributes to host 57 
nutrition1, 7, 8 and it impacts on intestinal cell proliferation and differentiation, pH, the development 58 
of the immune system and innate and acquired response to pathogens1, 9, 10. 59 
 Alterations in the composition of the intestinal microbiota have recently been linked to a 60 
variety of conditions ranging from Inflammatory Bowel Disease to allergy and obesity6, 11-14. 61 
Among the variable constituents of the microbiota are health-promoting indigenous species (or 62 
autochthonous microbiota), also known as probiotic bacteria, which are commonly consumed as 63 
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live dietary supplements15. The mechanisms by which probiotic micro-organisms beneficially affect 64 
human health (reviewed in16, 17) are typically divided into a number of general categories, including 65 
strengthening of the intestinal barrier, modulation of the immune response and antagonism of 66 
pathogens either by the production of antimicrobial compounds or through competition for mucosal 67 
binding sites16, 18. Although there is suggestive evidence for each of these functional claims, the 68 
molecular mechanisms remain largely unknown.  69 
Genomics offers the possibility of accelerating research into probiotic bacteria. In recent 70 
years, genome sequencing of gut commensals and symbionts has come to the fore, currently 71 
represented by the development of a novel scientific discipline, called probiogenomics19, which 72 
aims to provide insights into the diversity and evolution of commensal/probiotic bacteria and to 73 
reveal the molecular basis for their health-promoting activities. The integration of probiogenomics 74 
and functional genomic information with data on host gene expression in the human gut will expand 75 
our understanding of the roles of (probiotic) microbiota, microbe-microbe and host-microbe 76 
interactions. These “omics” approaches allow the simultaneous analysis of very large numbers of 77 
genes or proteins20. Probiogenomics is thus one strand of gut systems microbiology. Significantly, 78 
when studied in combination with host genome variation, probiogenomics offers a comprehensive 79 
systems model, even at individual subject level.  80 
Here we address current developments in analyzing the genome sequences of probiotic 81 
bacteria and how these data can be integrated in a global view using omics approaches in order to 82 
elucidate genome evolution and genetic adaptation of these bacteria to the human gut ecological 83 
niche. We consider the well recognized model probiotic bacteria Bifidobacterium spp. and 84 
Lactobacillus spp. which are phylogenetically distant (although well-characterized; Fig 1), have 85 
distinguishing properties, and different depths of biological characterization.   86 
 87 
 88 
 89 
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Bifidobacteria genomics 90 
The genus Bifidobacterium is relatively small, with 30 species, and a low level of phylogenetic and 91 
genomic diversity21. Bifidobacteria were originally isolated from a breast-fed infant23 and since 92 
then, 30 species have been isolated from the GIT contents of mammals, birds and insects19. Those 93 
bifidobacteria that may be isolated from the human intestine have attracted the interest of genomic 94 
research due to their probiotic properties. However, of the bifidobacterial taxa described to date, 95 
genomes of only three strains, which belong to the B. longum and B. adolescentis groups, have been 96 
sequenced to completion (Table 1).  The availability of genome sequences provided a genetic basis 97 
for the observation that bifidobacteria are extensively prototrophic, indicating that these bacteria are 98 
well adapted to grow in an environment such as the human colon, which is poor in certain growth 99 
substrates (e.g. vitamins, amino acids and nucleotides)24. In fact, bifidobacterial genome sequences 100 
available to date revealed that these organisms harbour genes for the synthesis of at least 19 amino 101 
acids and they encode all enzymes needed for the biosynthesis of pyrimidine and purine 102 
nucleotides, as well as those required for the synthesis of the B vitamins, folic acid, thiamine and 103 
nicotinate (25; Ventura et al., unpublished data; Leahy and D. van Sinderen, unpublished data). 104 
Annotation and pathway prediction revealed the presence of all the required genetic information to 105 
shunt many monosaccharides  or disaccharides  into the fructose-6-phosphate pathway24. 106 
Adaptation to the human gut. 107 
The amount and types of “non-digestible” saccharides in the diet (some of which are referred to as 108 
prebiotics) has a major influence on the numbers and metabolic activities of different groups of 109 
bacteria within the enteric microbiota26. The range of polysaccharide substrates that arrive in the 110 
intestine is extremely broad27. This diversity of carbon substrates potentially generates a vast array 111 
of ecological roles and niches that may be exploited by gut bacteria. Although some members of the 112 
gut microbiota can switch rapidly between different substrates (e.g. derived from diet or of host 113 
origin), others (e.g. those associated with insoluble substrates) are much more specialized28. In this 114 
context, bifidobacteria have a presumed ecological advantage due to their capacity to metabolize 115 
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complex sugars derived from the diet as well as from the host29. Genome annotation confirms that 116 
genes required for the breakdown of complex sugars are abundant in sequenced bifidobacterial 117 
genomes19. Over 8% of annotated bifidobacterial genes encode enzymes involved in carbohydrate 118 
metabolism. These include various glycosyl hydrolases (GH) for utilization of diverse, but in most 119 
cases un-identified, plant-derived dietary fibers or complex carbohydrate structures. Most of the 120 
bifidobacterial GHs are predicted to be intracellular including those that are thought to hydrolyze 121 
arabinogalactans and arabinoxylans, or starch and related polysaccharides25, 30, 31. The genes for 122 
these GHs are associated with genetic loci for the uptake of structurally diverse sugar substrates. In 123 
fact, about 5% of the total bifidobacterial gene content is dedicated to sugar internalization, through 124 
ABC transporters, permeases, and proton symporters rather than phosphoenolpyruvate-125 
phosphotransferase systems (PEP-PTSs)25, 32, 33. Bifidobacteria utilize a kind of docking station to 126 
sequester and capture high molecular weight carbohydrates molecules (e.g., xylose- and arabinose-127 
containing polysaccharides; Fig. 2) and bind these to their cell surface30, 33, presumably to avoid 128 
losing them to nearby competitors. This is reminiscent of a putative carbohydrate utilization system 129 
identified in the genome of L. plantarum34, and a system used by Bacteriodes  thetaiotaomicron for 130 
starch utilization35. Enteric bifidobacteria are also able to utilize sialic acid-containing complex 131 
carbohydrates in mucin, glycosphingolipids and human milk36, 37. Thus, these bifidobacteria have 132 
acquired adaptations to allow them to exploit a rich repertoire of otherwise indigestible components 133 
of the human or animal diet.  134 
Characterization of the metabolism of prebiotic compounds by bifidobacteria has identified specific 135 
transporters and hydrolases for oligosaccharides30, 38, 39. These studies indicated that bifidobacteria 136 
ferment different types of fructo-oligosaccharides (FOS); accordingly, the respective FOS 137 
metabolism operons possess different genetic architectures40, suggesting that these genes were 138 
acquired following evolutionary divergence of the species. Prebiotic oligosaccharides are also 139 
contained in human milk (e.g., galacto-oligosaccharides), which are hydrolyzed by bifidobacteria 140 
through the action of extracellular enzymes encoded by the galA gene30, 41. In addition to galacto-141 
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oligosaccharides, human milk consumption provides large amounts of small peptides that are 142 
derived from the digestion of milk proteins by the gastric protease pepsin42. Bifidobacterium 143 
genomes encode a rich repertoire of enzymes involved in the breakdown and internalization of 144 
peptides such as dipeptidyl aminopeptidases and oligopeptide uptake systems (Ventura et al., 145 
unpublished data). 146 
Molecular interaction with the host. 147 
Bacterium-host interactions that result in host benefit can be elucidated by identification and 148 
detailed molecular analysis of the bacterial proteins or macromolecules involved. For example a 149 
potential probiotic effector molecule, a eukaryotic-type serine protease inhibitor (serpin) was 150 
identified in the genome of B. longum subsp. longum25, 43. Members of the serpin family regulate a 151 
wide range of signalling pathways in eukaryotes and some are recognized for their ability to 152 
suppress inflammatory responses by inhibiting elastase activity44. Recent findings showed that the 153 
bifidobacterial serpin-like protein performs an immunomodulatory role in a murine colitis model, 154 
by reducing intestinal inflammation 43. 155 
Transcriptomic approaches facilitate studies of gene expression profiles and have been 156 
successful in studying how individual organisms in bacterial communities affect each other’s 157 
transcriptome. Recent transcriptomic analyses were performed on bacteria from germ-free mice that 158 
had been mono-associated with B.  thetaiotaomicron —one of the dominant components of the 159 
human gut microbiota — and subsequently challenged with B. longum subsp. longum . The 160 
presence of B. longum subsp. longum provoked an expansion in the diversity of polysaccharides 161 
targeted for breakdown by B. thetaiotaomicron such as mannose and xylose-containing glycans45. 162 
The changes in the transcriptional profiles of polysaccharide-utilization related genes by B. longum 163 
subsp. longum and B. thetaiotaomicron may imply the existence of symbiosis between these 164 
microbial species, where each species possesses a complement of GH activities, which when 165 
combined allow both to participate in a synergic harvest of xylose and mannose-containing sugars. 166 
This phenomenon has already been described in other microbial communities that degrade 167 
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cellulose46. Alternatively, the shifts in transcription patterns could represent response to competition 168 
(see also below for lactobacilli). 169 
The elucidation of the molecular impact generated by members of the human microbiota on 170 
the human host was also analysed by studying the host epithelium response to co-colonization by B. 171 
longum subsp. longum and B. thetaiotaomicron45. Remarkably, the host response to these two 172 
bacterial species was different. In fact, the host response to B. thetaiotaomicron was more focused 173 
on tumor necrosis factor α and LPS-responsive cytokine produced by natural killer and T 174 
macrophages, whereas B. longum subsp. longum promoted the activation of T-cell-produced 175 
cytokine interferon-γ and reduced production by the host of antibacterial proteins such as Reg3γ 176 
(Regenerating islet-derived-3γ) and Pap (Pancreatitis-associated protein). Thus the host response to 177 
enteric bifidobateria may not only promote their own survival in the human intestine but also affect 178 
the composition of the overall human gut microbiota.  179 
 180 
Comparative genomics of bifidobacteria 181 
Comparisons at the nucleotide level of the fully sequenced bifidobacterial genomes revealed a high 182 
degree of conservation and synteny across the entire genomes19. However, several breakpoint 183 
regions were also reported, apparently representing inversions or DNA deletion/insertion points. 184 
DNA regions uniquely present in one genome and absent in others were also identified. Most of 185 
these correspond to genetic elements presumably acquired by horizontal gene transfer events 186 
(HGT), including prophage-like elements, restriction modification systems, integrative plasmids, 187 
and genes involved in the biosynthesis of extracellular structures such as exopolysaccharides (EPS) 188 
(Fig. 3). Another set of genes disseminated via HGT in bifidobacteria is the CRISPR-related system 189 
(CASS) implicated in defence against phages and plasmids47, which have been identified in the 190 
genome of B. dentium Bd1 as well as in the genome of B.  breve UCC2003 (Ventura et al., 191 
unpublished data; Leahy and D. van Sinderen, unpublished data). Notably these in silico analyses 192 
were also confirmed by comparative genome hybridization analyses48. 193 
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 There is relatively little phylogenetic diversity within the genus Bifidobacterium compared 194 
to Lactobacillus (see below). This is underlined at whole genome level when one compares the oral 195 
species (B. dentium), which is frequently identified as a component of the microbiota associated 196 
with dental caries49 with the probiotic species B. adolescentis (Fig. 3). Despite the large phenotypic 197 
differences, there is a remarkable degree of overall synteny. This reductionist model of genome 198 
evolution may be useful for identifying niche-specific genes and genes related to specialized 199 
phenotypes. 200 
 201 
Genomics of Lactobacillus  202 
The genus Lactobacillus has more than 100 species, and is noteworthy for its extreme phylogenetic, 203 
phenotypic and ecological diversity22. The microbiological characterization of lactobacilli is 204 
historically better developed than that of bifidobacteria, but the genomic analysis is similarly recent. 205 
Of the 14 sequenced and published Lactobacillus genomes, eight (L. acidophilus, L. casei, L. 206 
fermentum, L. gasseri, L. johnsonii, L. reuteri, L. salivarius and L. plantarum) are from 207 
cultures/species considered probiotic (Table 1). Interestingly, 11% of the overall coding capacity of 208 
the L. salivarius genome lies on the first megaplasmid described in lactic acid bacteria; pMP11822. 209 
This megaplasmid encodes biologically important features such as a locus for bacteriocin 210 
production, a bile salt hydrolase, and two genes that complete the phosphoketolase pathway, 211 
officially reclassifying this organism as a facultative heterofermenter22. In fact, plasmids account for 212 
15% of the genome of L. salivarius, which is not the case with other sequenced probiotic 213 
lactobacilli, even though members of this genus are considered relatively replete with plasmids9. 214 
Adaptation to the human gut. 215 
The metabolic diversity revealed by the Lactobacillus genome sequences available to date is 216 
illustrated in Fig 4. Taking the L. plantarum WCFS1 genome as reference, it is clear that there is 217 
considerable variation in the COG assignments of the gene sets harboured by the respective 218 
genomes. Intestinal lactobacilli compensate for their relative degree auxotrophy by being rich in 219 
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genes for transporters. Their genomes also contain genes that encode  acid and bile resistance, 220 
capacity for uptake of macromolecules, metabolism of complex carbohydrates, and cell surface 221 
proteins that interact with the intestinal mucosa60. More strikingly than is evident for bifidobacteria, 222 
this adaptation to life in the GIT is further evident when the genome sequences of intestinal isolates 223 
are compared with food-adapted lactobacilli such as L. bulgaricus and L. helveticus. L. bulgaricus. 224 
The latter, which is widely used as a starter culture in yogurt fermentations, has undergone genome 225 
decay to adapt to the milk environment53, and thus harbours numerous degraded or partial 226 
carbohydrate pathways and harbours bile salt hydrolase pseudogenes53, 60. In addition, L. bulgaricus 227 
shows a preference for growth in lactose, further emphasizing its niche adaptation to milk. The 228 
genome sequence of L. helveticus, a widely used cheese starter culture, has been reported recently52. 229 
Compared to the closely related L. acidophilus, L. helveticus has additional genes for fatty acid 230 
biosynthesis and specific amino acid metabolism, but notably fewer cell surface proteins and  PEP-231 
PTS systems for sugar utilization52. Additionally, no functional mucus binding proteins or 232 
transporters for complex carbohydrates such as raffinose and fructooligosaccharides are encoded by 233 
the L. helveticus genome, reflecting the degree of adaptation of L. helveticus to a milk environment.  234 
In contrast, L. acidophilus has adapted to the gut ecological niche by retaining the functional gene 235 
sets lacking in L. helveticus, emphasizing their importance for probiotic functionality and niche 236 
adaptation by autochthonous lactobacilli naturally residing in the GIT. 237 
Several studies have examined commensal Lactobacillus gene expression in animal model systems. 238 
Using a stringent lincomycin-resistance based selection, Walter and colleagues identified 239 
surprisingly only three genes that were differentially expressed in vivo 69. Bron  et al. 70 used a 240 
modified in vivo expression technology to identify 72 genes expressed by L. plantarum in the 241 
mouse GIT, most of which were associated with carbon metabolism, amino acid metabolism, and 242 
stress resistance70, and many of which were functions previously identified as survival/adaptation 243 
factors in pathogens. L. casei actively transcribes metabolic genes in the murine intestine, and 244 
initiates de novo protein synthesis71. L. johnsonii NCC533 expresses different sets of genes 245 
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depending on its location in the GIT72, and surprisingly, 44% of the genome remains untranscribed 246 
either in vitro or in vivo 72. Interestingly, the prolonged murine gut persistence of NCC533 but not 247 
of L. johnsonii was recently shown to induce expression of exopolysaccharide synthesis genes, 248 
mannose uptake genes and a gene for a putative protease in this strain73. In summary, while there 249 
are tantalizing glimpses of commensal Lactobacillus gene expression in vivo, these are as yet 250 
limited to animal models; data from human volunteer studies is keenly awaited.  251 
Molecular basis of the interaction with other commensal bacteria. 252 
Although the biology of commensal bacteria can be investigated in isolation, it must ultimately be 253 
understood in the context of the extremely complex intestinal ecosystem61. Lactobacillaceae 254 
account for approximately 36 phylotypes among the >1000 phylotypes in the human 255 
gastrointestinal microbiota5. In the short term, intervention studies in animal models and human 256 
subjects provide the key insights into our current understanding of interaction with other 257 
commensals. 258 
Some lactobacilli may have quite subtle effects on the microbiota. Consumption of L. rhamnosus 259 
DR20 transiently altered the levels of lactobacilli, bifidobacteria, enterococci, and Bacteroidetes, 260 
but the variations were generally small62 and mechanisms were not investigated. The development 261 
of genomic tools facilitated a study45, in germ-free mice that were mono-associated with B. 262 
thetaiotaomicron, B. longum, L. casei, or combinations of these organisms45. Presence of L. casei 263 
resulted in an expanded capacity of B. thetaiotaomicron to metabolize polysaccharides, and 264 
increased expression of genes for inorganic ion transport and metabolism45. The L. casei-induced 265 
changes in the Bacteroides transcriptome were functionally similar to those caused by B. longum, 266 
but distinct from those induced by administration of B. animalis to the mice. Administration of L. 267 
paracasei or L. rhamnosus to germ-free mice colonized with human infant microbiota caused 268 
modest changes in levels of a limited number of species monitored by culture techniques, but major 269 
changes to levels of diverse metabolites including amino acids, methylamines and short-chain fatty 270 
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acids63. The metabolism of the administered probiotics, coupled with competition for substrates and 271 
small molecules, are the likely reasons for the transcriptional and metabolite alterations described in 272 
these studies.  273 
Numerous studies have reported that administration of probiotics benefits a range of gastrointestinal 274 
conditions and infections64, 65, but mechanistic insights are generally lacking. Reduction in vaginal 275 
Lactobacillus levels that leads to vaginosis has been linked to production of a bacteriocin-like 276 
substance by commensal enterococci66. From the opposite perspective, the ability of L. salivarius to 277 
eliminate Listeria monocytogenes in a mouse model was dependent on production of the broad 278 
spectrum bacteriocin Abp118/salivaricin67, and bacteriocin-producing lactobacilli become dominant 279 
among strains in a cocktail that reduce Salmonella shedding in pigs68. Thus bacteriocin production 280 
is likely an important general mechanism in the interaction of many lactobacilli and other 281 
commensals.  282 
 283 
Comparative genomics of Lactobacillus. 284 
Sequencing of the genomes of twenty lactic acid bacteria (LAB) has demonstrated that loss and 285 
decay of ancestral genes has played a key role in the evolution of Lactobacillales. Lactobacillales 286 
diverged from their Bacillus ancestor with an estimated loss of 600-1200 genes from a total gene 287 
repertoire of 2,100 to 2,20050. Many of these genes encoded biosynthetic enzymes or functioned in 288 
the sporulation process50. However, in addition to major gene losses, gene gains also occurred 289 
which appear to reflect the nutrient-rich niches occupied by the LAB, such as milk and the GIT. For 290 
example, genes encoding for peptidases, amino acid transport proteins and genes involved in the 291 
metabolism and transport of carbohydrates have been duplicated50. In addition, comparative 292 
analysis between GIT-associated species L. acidophilus, L. gasseri, and L. johnsonii and the dairy 293 
species L. bulgaricus and L. helveticus revealed selective pressure from niche-specific adaptation on 294 
the genome evolution of these species51-53.  295 
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In addition to gene duplication, HGT is also evident in probiotic lactobacilli. For example, the 296 
metabolic diversity of L. plantarum is underpinned by the expanded coding capacity afforded by its 297 
larger 3 Mb genome, and a low-GC-content region coding for sugar transport and metabolism genes 298 
which is likely to have been acquired by HGT54. Genes encoding cell surface factors in L. johnsonii 299 
and the exopolysaccaride cluster in the L. acidophilus complex are further examples of HGT in 300 
probiotic lactobacilli52, 55. Moreover, production of reuterin (3-hydroxypropionaldehyde), a potent 301 
broad-spectrum antimicrobial compound56, is encoded by a genomic island which is present in some 302 
L. reuteri strains57-59, and absent in the sequenced genome of a mouse L. reuteri isolate58 and the 303 
closely related L. fermentum59.  304 
With genomes of 12 of the 147 recognized species74 now fully sequenced, Lactobacillus has been 305 
targeted for several comparative whole-genome analyses. Beginning with the report of extreme 306 
diversity between the first two available genomes34, genome sequencing of L. acidophilus, L. 307 
gasseri, L. delbrueckii and L. helveticus allowed a more focused attention on the ‘acidophilus 308 
complex’25, 52, 75. Large regions of synteny were observed between the species25, 52. Multi-locus 309 
sequence analysis of five housekeeping genes, comparative-genome hybridizations and DNA-310 
typing showed consistent and stepwise-decreasing levels of similarity within the group, suggesting 311 
a strong role for vertical evolution25. Conversely, differences between trees from 16S rRNA genes 312 
and 401 core genes from L. acidophilus, L. johnsonii and L. delbrueckii indicated a much higher 313 
level (40%) of HGT75.  314 
In order to infer robust phylogenetic relationships with minimal incongruence, or to elucidate 315 
functional differences between species, a set of carefully selected single-copy ubiquitously-present 316 
genes is necessary. A comparison of 354 core genes from five lactobacilli underscored the 317 
substantial diversification of the genus, and suggested a subgeneric division into three groups 21. 318 
Furthermore, two overlapping comparative studies, encompassing nine additional Lactobacillales 319 
genomes, saw the expansion of the gene core to 567 order-specific genes50, 76. Similarly, the 320 
majority of these encoded information-processing proteins. The finer granularity provided by 321 
 14
LaCOGs (Lactobacillales-specific COGs) allowed detection of two genes, whose gene-contexts 322 
suggest housekeeping and protein-modification functions. Recently, we extracted 141 core genes 323 
from 12 Lactobacillus genomes to investigate the case for a single congruent genus phylogeny22. 324 
Although this proved impossible at the time, four sub-generic groups were reliably distinguished. 325 
These were operationally characterized by absent genes rather than gained/retained genes, 326 
consistent with the findings of an earlier study76. 327 
 328 
Common evolutionary trends in probiotic genomes 329 
Collective analyses of probiotic genome sequences so far available — the probiome — has revealed 330 
some generally conserved genetic traits22, 25, 52, 54, 55, 59, 76, which may reflect adaptation to the 331 
intestinal niche 1. However, since probiotic bacteria represent diverse and taxonomically 332 
heterogeneous groups of microorganisms, the analysis of phyletic (phylogenetic) patterns, i.e. 333 
patterns of gene presence/absence in a particular set of genomes, may be overwhelmingly 334 
influenced by the evolutionary distance between these two distant phyla. Nevertheless, common 335 
trends in the evolution of both Bifidobacterium and Lactobacillus genomes may be discerned. These 336 
include gene loss (e.g. of genes encoding biosynthetic enzymes), gene duplication and HGT. The 337 
adaptation of probiotic bacteria to successfully exist and compete in the human gut must have been 338 
driven by the occurrence of DNA duplications and genetic acquisitions during their evolution. 339 
Many genes involved in sugar metabolism and transport were duplicated or acquired early in the 340 
evolution of probiotic bacteria, including those encoding enolase, β-galactosidase, and many other 341 
GH50. In addition, expansion of peptidases and amino acid transporters has occurred in several 342 
lineages of Lactobacillales and bifidobacteria. Furthermore, several expanded families include 343 
proteins involved in antibiotic resistance in other bacteria, i.e. β-lactamases77.  344 
Horizontal gene transfer via bacteriophage-mediated or conjugative pathways has been extensively 345 
documented in Lactobacillales and appears to be important for niche-specific adaptation in 346 
probiotic bacteria. In probiotic lactobacilli, HGT played an important role in shaping the common 347 
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ancestor, in which 84 genes were inferred to be horizontally transferred from different sources50. In 348 
some cases, the ancestor acquired an additional pseudoparalogous copy of a gene by HGT (e.g. 349 
enolase in Lactobacillales) while on other occasions, xenologous displacement, i.e., acquisition of 350 
genes by HGT followed by the loss of the ancestral orthologous gene78 apparently took place.   351 
A provocative future challenge will involve the identification of the hypothetical core 352 
probiogenome, representing core genome functions of probiotic bacteria. However, only seven 353 
genes present in the bifidobacteria but not in the genomes of the other members of the 354 
Actinobacteria phylum are shared with Lactobacillales. Only one of these genes, which encodes a 355 
functionally uncharacterized membrane protein, is present in all the Lactobacillales genomes so far 356 
sequenced 50.  357 
 358 
Conclusions and future considerations 359 
Most of the probiotic bacteria marketed today were originally selected on the basis of technological 360 
stability or by a variety of easily measurable phenotypes such as ability to tolerate bile salts or 361 
survive GIT passage, but not necessarily for their ability to promote health benefits. It is crucial to 362 
identify the precise mechanisms by which such probiotic microorganisms influence human health. 363 
Such studies should be accelerated by omics approaches involving genomics and functional 364 
analyses. Molecular interaction models are being currently developed, although more are required, 365 
that monitor the activation of cellular and systemic responses in vivo in animal models and in 366 
feeding trial participants through the measurement of previously validated biomarkers. The 367 
combination of verified molecular models with functional and comparative genomics-based 368 
approaches should enable selection of the most appropriate probiotic strain for a particular health 369 
benefit or improvement of strain processing and administration regimes that optimize the 370 
established health effect. Finally, this might allow the selection of specific probiotics for a particular 371 
human genotype, in analogy to personalized genomic medicine efforts. 372 
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Several issues regarding the sequences of complete probiotic bacterial genomes remain unresolved 373 
at present. So far, only a limited number of completed probiotic bacterial genome sequences are 374 
available, which only partially represent the total biodiversity of probiotic bacteria residing in the 375 
human gut. In this context, understanding of the human gut microbiome will be an important 376 
challenge for the future79. Furthermore, sequencing the genomes of environmental organisms and 377 
carrying out metagenomic surveys of diverse gut environments (human vs. animal GIT) will 378 
provide not only an improved understanding of microbial biodiversity but also insights into the 379 
evolution of bacterial factors  that may be crucial for the commensals (probiotics) establishment in 380 
these different gut niches80. 381 
The first decade of bacterial genomics has afforded unprecedented insights into the evolution of 382 
bacterial pathogens (bacterial pathogenomics)81. The next decade holds the promise of being even 383 
more rewarding as the new discoveries about probiotic bacteria provided by probiogenomic efforts 384 
are exploited. 385 
 386 
GLOSSARY 387 
Omics: The integration of genomics methodology and data with functional genomic analyses 388 
involving transcriptomics, proteomics, metabolomics and interactomics.  389 
Microbiota: The collective microbial community or population resident in a particular locale at a 390 
given time-point. 391 
Microbiome: The collective genome of the human microbial communities  392 
Prebiotics: Growth substrates that are preferentially (or ideally, exclusively) metabolized by a single 393 
genus or species, and that may thus be used as dietary supplements to promote growth of a targeted 394 
microorganism. 395 
Transcriptome: Subsets of genes transcribed in an organism. It represents dynamic links between 396 
genomes, proteins and cellular phenotypes.  397 
Synteny: Genetic linkage or conservation of gene order. 398 
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COGs: Clusters of Orthologous Groups are delineated by comparing protein sequences encoded in 399 
complete genomes, representing major phylogenetic lineages. Each COG consists of individual 400 
proteins or groups of paralogs from at least 3 lineages and thus corresponds to an ancient conserved 401 
domain. 402 
Neighbour-joining tree: Tree that reconstruct the evolutionary development of organisms based on 403 
distances between each pair of taxa.  404 
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Table 1: General features of sequenced Bifidobacterium and Lactobacillus genomes. 
 
Species Genome size (bp) %GC Gene numbers Proteins Source Accession number Reference 
B. longum subsp. longum NCC2705 2,256,640 60% 1798 1727 Human GIT NC_004307 25 
B. longum subsp. longum DJ010A 2,375,286 59% 1908 1908 Human GIT NC_010816 82  
B. breve UCC2003 2422668 59% 1868  Infant feces Project ID: 13487 83 
B. adolescentis ATCC15703 2,089,645 59% 1701 1631 Human GIT NC_008618 - 
B. adolescentis L2-32 2,385,710 59% 2499 2428 Infant feces NZ_AAXD00000000 - 
B. animalis subsp. lactis HN019 1,915,892 60% 1632 1578 - NZ_ABOT00000000 - 
Lactobacillus acidophilus NCFM 1,993,560 34% 1936 1862 Human GIT NC_006814 52  
Lactobacillus casei ATCC334 2,895,264 46% 2909 2751 Emmental cheese NC_008526 76  
Lactobacillus gasseri ATCC33323 1,894,360 35% 1898 1755 Human GIT NC_008530 50  
Lactobacillus jonsonii NCC533 1,992,676 34% 1918 1821 Human GIT NC_005362 55  
Lactobacillus plantarum WCFS1 3,308,274 44% 3135 3007 Human saliva NC_004567 54  
Lactobacillus reuteri F275 1,999,618 38% 2027 1900 Human GIT NC_009513 60 
Lactobacillus fermentum IFO 3956 2,098,685 51% 1912 1843 - NC_010610 60 
Lactobacillus salivarius susp. salivarius UCC118 1,827,111 32% 1864 1717 Human GIT NC_007929 22  
        
 24
LEGENDS 
 
Figure 1: Ecological, evolutionary and morphological overview of bifidobacteria and lactobacillae. 
[A| Schematic representation of the biological relationships between bacteria and the human body. 
Commensalisms or symbiosis is a consequence of the co-evolution of host-bacterial relationships. 
B| Evolutionary relationships between the main GIT commensal bacterial groups (bifidobacteria on 
the left and lactobacillae on the right) based on neighbour-joining tree  of 16S rRNA genes 
sequences. Bar indicates scale for computed distances. Bacterial taxa for which the whole genome 
sequences is available are shaded in blue, whereas for those that is still on progress are shaded in 
grey. C| electron micrographs illustrating the cell morphology of bifidobacteria (e.g., B. breve 
UCC2003) (right panel) and lactobacillae (e.g., L. salivarius UCC118) (Left panel). Both scanning 
electron microscope images were prepared by. S. Leahy, Univ. College Cork and D. John, Trinity 
College Dublin. Magnification ca. 20,000 fold; scale bar is 2 micrometres. 
 
 
Figure 2: Putative strategy adopted by bifidobacteria to secure sugar nutrients for their own benefit.  
Bifidobacteria use a kind of docking station to capture complex sugars (e.g., xylan and arabino 
based molecules) and bind these to the bacterial cell surface, without loosing them to nearby 
competitors. In the latter case the docking station is a complex of modular glycanases, which are 
anchored at the cell surface by a transmembrane domain. The enzymatic activities degrade the 
arabinoxylan molecules to oligosaccharides that are subsequently transported across the bacterial 
membrane by a transporter protein; the presence of the bacterial cell wall may prohibit diffusion of 
these nutrients away from the transporter. 
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Figure 3. Comparative analysis of Bifidobacterium genomes. A| A comparison of the B. dentium 
Bd1 and B. adolescentis ATCC15703 genomes. B| Comparison of gene order conservation between 
two genome pairs, illustrating different forms of bifidobacterial genome evolution. X and Y axes 
represent the linearised chromosomes of B. dentium Bd1 and B. adolescentis ATCC15703, 
respectively.  
Figure 4. Comparative analysis of Lactobacillus genomes. Circular genome atlas of L. plantarum 
WCFS1 with mapped orthologs (defined as reciprocal best FastA hits with more than 30% identity 
over at least 80% of both protein lengths) in 13 publicly available Lactobacillus genomes. The outer 
circle shows L. plantarum followed, inwards, by L. salivarius, L. brevis, L. reuteri F275, L. reuteri 
F275 (Japanese), L. fermentum, L. acidophilus, L. helveticus, L. johnsonii, L. gasseri, L. bulgaricus 
ATCC 11842, L. bulgaricus ATCC BAA-365, L. casei, L. sakei, G+C percentage, and GC skew 
(window-sizes 10,000 bp). Red colour represents COG categories in Metabolism, green - 
Information Storage and Processing, blue - Cellular Processes and Signalling, and grey - poorly or 
not categorised. 
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